XML 51 R34.htm IDEA: XBRL DOCUMENT
v3.21.2

ASSETS IMPAIRMENTS AND RESTRUCTURING (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Restructuring Costs and Asset Impairment Charges [Abstract] |
Schedule of Restructuring Reserve by Type of Cost [Table Text Block] | The following table summarizes the changes in asset impairments and restructuring charges, the non-cash reductions attributable to asset impairments, and the cash reductions in restructuring reserves for severance costs and site closure costs paid in first nine months 2021 and full year 2020:
(Dollars in millions) | Balance at January 1, 2021 |  | Provision/ Adjustments |  | Non-cash Reductions/ Additions |  | Cash Reductions |  | Balance at September 30, 2021
Non-cash charges | $ | — |  |  | $ | 5 |  |  | $ | (5) |  |  | $ | — |  |  | $ | — |
Severance costs | 65 |  |  | 1 |  |  | — |  |  | (47) |  |  | 19 |
Other restructuring costs | 14 |  |  | 23 |  |  | — |  |  | (23) |  |  | 14 |
Total | $ | 79 |  |  | $ | 29 |  |  | $ | (5) |  |  | $ | (70) |  |  | $ | 33 |
(Dollars in millions) | Balance at January 1, 2020 |  | Provision/ Adjustments |  | Non-cash Reductions/ Additions |  | Cash Reductions |  | Balance at December 31, 2020
Non-cash charges | $ | — |  |  | $ | 145 |  |  | $ | (145) |  |  | $ | — |  |  | $ | — |
Severance costs | 17 |  |  | 65 |  |  | 1 |  |  | (18) |  |  | 65 |
Other restructuring costs | 11 |  |  | 17 |  |  | — |  |  | (14) |  |  | 14 |
Total | $ | 28 |  |  | $ | 227 |  |  | $ | (144) |  |  | $ | (32) |  |  | $ | 79 |
Restructuring and Related Costs [Table Text Block] |
(Dollars in millions) | Third Quarter |  | First Nine Months
Tangible Asset Impairments | 2021 |  | 2020 |  | 2021 |  | 2020
Site optimizations |  |  |  |  |  |  |
AFP - Tire additives (1) | $ | — |  |  | $ | — |  |  | $ | 4 |  |  | $ | 5 |
AM - Advanced interlayers (2) | — |  |  | — |  |  | 1 |  |  | — |
AM - Performance films (3) | — |  |  | — |  |  | — |  |  | 4 |
AFP - Animal nutrition (4) | — |  |  | — |  |  | — |  |  | 3 |
Discontinuation of growth initiatives (5) | — |  |  | — |  |  | — |  |  | 8 |
| — |  |  | — |  |  | 5 |  |  | 20 |
Gain on Sale of Previously Impaired Assets |  |  |  |  |  |  |
Site optimizations |  |  |  |  |  |  |
AFP - Animal nutrition (4) | — |  |  | — |  |  | (1) |  |  | — |
| — |  |  | — |  |  | (1) |  |  | — |
Intangible Asset Impairments |  |  |  |  |  |  |
AFP - Tradenames (6) | — |  |  | — |  |  | — |  |  | 123 |
AFP - Customer relationships (7) | — |  |  | — |  |  | — |  |  | 2 |
| — |  |  | — |  |  | — |  |  | 125 |
Severance Charges |  |  |  |  |  |  |
Business improvement and cost reduction actions (8) | — |  |  | 46 |  |  | — |  |  | 46 |
CI & AFP - Singapore (9) | — |  |  | 2 |  |  | — |  |  | 5 |
Site optimizations |  |  |  |  |  |  |
AM - Advanced interlayers (2) | — |  |  | 3 |  |  | 1 |  |  | 3 |
AFP - Tire additives (1) | — |  |  | 1 |  |  | — |  |  | 1 |
AM - Performance films (3) | — |  |  | — |  |  | — |  |  | 3 |
AFP - Animal nutrition (4) | — |  |  | — |  |  | — |  |  | 1 |
| — |  |  | 52 |  |  | 1 |  |  | 59 |
Other Restructuring Costs |  |  |  |  |  |  |
Cost reduction initiatives (8) | — |  |  | 7 |  |  | — |  |  | 7 |
Discontinuation of growth initiatives contract termination fees (5) | — |  |  | 1 |  |  | — |  |  | 4 |
CI & AFP - Singapore (9) | 3 |  |  | — |  |  | 16 |  |  | — |
Site optimizations |  |  |  |  |  |  |
AM - Advanced interlayers (2) | 1 |  |  | — |  |  | 3 |  |  | — |
AFP - Tire additives (1) | 1 |  |  | — |  |  | 3 |  |  | — |
AM - Performance films (3) | 2 |  |  | — |  |  | 2 |  |  | — |
| 7 |  |  | 8 |  |  | 24 |  |  | 11 |
Total | $ | 7 |  |  | $ | 60 |  |  | $ | 29 |  |  | $ | 215 |
(1)Asset impairment charges, severance costs, and site closure costs in the AFP segment from the previously reported closure of a tire additives manufacturing facility in Asia Pacific as part of ongoing site optimization. (2)Asset impairment charges, severance costs, and site closure costs in the Advanced Materials ("AM") segment due to the previously reported closure of an advanced interlayers manufacturing facility in North America as part of ongoing site optimization. In addition, accelerated depreciation of $4 million in first nine months 2021 and $7 million in third quarter and first nine months 2020 was recognized in "Cost of sales" in the Unaudited Consolidated Statements of Earnings, Comprehensive Income and Retained Earnings related to the closure of this facility. Management expects total charges of up to $30 million for the closure of this facility, primarily reported in "Cost of sales" and in "Asset impairments and restructuring charges, net" in the Unaudited Consolidated Statements of Earnings, Comprehensive Income and Retained Earnings, of which $13 million was recognized in 2020. (3)Fixed asset impairment charges and severance costs in the AM segment from the previously reported closure of a performance films manufacturing facility in North America as part of ongoing site optimization. (4)Fixed asset impairment charges, net and severance costs in the AFP segment from the previously reported closure of an animal nutrition manufacturing facility in Asia Pacific as part of ongoing site optimization. (5)Fixed asset impairment charges and contract termination fees resulting from management's decision to discontinue growth initiatives for polyester based microfibers, including Avra TM performance fibers, the financial results of which were not allocated to an operating segment and reported in "Other". (6)Intangible asset impairment charges in the AFP segment tire additives business to reduce the carrying values of the Crystex TM and Santoflex TM tradenames to the estimated fair values. The estimated fair values were determined using an income approach, specifically, the relief from royalty method, including some unobservable inputs. The impairments were primarily the result of weakened demand in the transportation markets impacted by COVID-19 and increased competitive pricing pressure as a result of global capacity increases. (7)Intangible asset impairment charge in the AFP segment for customer relationships. (8)Severance and related costs as part of business improvement and cost reduction initiatives which were reported in "Other". (9)Site closure costs in third quarter 2021 of $2 million and $1 million in the Chemical Intermediates ("CI") and AFP segments, respectively, and site closure costs, including contract termination fees, in first nine months 2021 of $13 million and $3 million in the CI and AFP segments, respectively, and severance charges in third quarter and first nine months 2020 of $1 million and $5 million, respectively, in the CI segment, resulting from the previously reported plan to discontinue production of certain products at the Singapore manufacturing site. Excluding the fixed asset impairments in 2019, restructuring charges of up to $50 million are expected for this closure, of which $6 million was recognized in 2020.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringCostsAndAssetImpairmentChargesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)(2)) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration